Clinical Trials Sponsored by Gedeon Richter Plc.

Total 38 results

Gedeon Richter Plc.

Recruiting

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Spain, Czechia, Italy, France
Gedeon Richter Plc.

Completed

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Healthy

United Kingdom
Gedeon Richter Plc.

Completed

A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults

Healthy Volunteers; | Obese, Otherwise Healthy Volunteers

United Kingdom
Gedeon Richter Plc.

Completed

Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta

Bioequivalence

United Kingdom
Gedeon Richter Plc.

Completed

Cariprazine: Comparison of Slow- and Immediate-release Forms

Pharmacokinetic Profile

United Kingdom
Gedeon Richter Plc.

Unknown

Comparative Pharmacokinetic Trial of RGB-03 and MabThera

Rheumatoid Arthritis
Gedeon Richter Plc.

Recruiting

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Schizophrenia

Mexico, United States, Bulgaria, Colombia, Romania, Russian Federation, Serbia, Ukraine
Gedeon Richter Plc.

Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Poland, United States, Spain, Hungary, Italy, Czechia, Bulgaria, Ukraine
AbbVie
Gedeon Richter Plc.

Recruiting

Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

Healthy Participants | Generalized Anxiety Disorder (GAD)

United States
Gedeon Richter Slovakia, s.r.o.

Completed

Trial Protocol GlobiFer - Oral Iron Repletion (TPG)

Iron Deficiency

Slovakia
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in Patients With Chronic Stable Schizophrenia

Schizophrenia

United States, India, Malaysia, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Schizophrenia

Schizophrenia

United States, Colombia, India, South Africa
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Bipolar Depression

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania

Bipolar Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Study of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Colombia, India, Romania, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Bipolar I Disorder

United States, Hungary, Poland, Spain
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Malaysia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Romania, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Schizophrenia

United States, India, Romania, Slovakia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Major Depressive Disorder

United States, Estonia, Finland, Slovakia, Sweden, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Mania

Bipolar Disorder | Mania

United States, India
Center for Epidemiology and Health Research, Germany
Gedeon Richter Plc.

Terminated

European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception (EURAS-CORA)

Contraception

Germany
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION...
Gedeon Richter Plc.

Completed

Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques (NACRE)

Infertility, Female | Fibroid Uterus

France, New Caledonia
Assistance Publique - Hôpitaux de Paris
Gedeon Richter Ltd.

Completed

Adenomyosis and Ulipristal Acetate (FRA-IIT-UPA)

Adenomyosis

France
Shanghai Rxmidas Pharmaceuticals Co. Ltd.
Gedeon Richter Ltd.

Completed

Chinese Assessment for Vinpocetine In Neurology (CAVIN)

Cerebral Infarction

China
Nicholas Macklon
Gedeon Richter Ltd.; Igenomix

Completed

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2 (RIOTC)

IVF

Denmark
Instituto Valenciano de Infertilidade de Lisboa
Gedeon Richter Ltd.

Recruiting

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

Frozen Embryo Transfer

Portugal
University Hospital, Ghent
University Hospital, Antwerp; AZ Jan Palfijn Gent; Gedeon Richter Plc.; Our Lady...

Terminated

Myo-inositol Versus Clomiphene Citrate in PCOS

Polycystic Ovary Syndrome | Ovulation Induction | Clomiphene | Inositol

Belgium
Assistance Publique - Hôpitaux de Paris
Gedeon Richter France; Collège National des Gynécologues et Obstétriciens Français

Recruiting

Fertility After Uterine Artery Embolization (FERTI-EMBOL)

Fertility Issues | Fertility Disorders | Myoma;Uterus | Uterine Artery Embolisation

France
Jan Vaclavík
Brno University Hospital; Gedeon Richter Ltd.; Czech Society of Hypertension; Prostejov... and other collaborators

Unknown

Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)

Hypertension

Czech Republic
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

Healthy

United States
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Healthy

United States

Clinical Trials Sponsored by Gedeon Richter Plc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations